LBX Pharmacy Chain Joint Stock Company (SHA:603883)
18.63
-0.75 (-3.87%)
May 22, 2025, 2:45 PM CST
SHA:603883 Revenue
LBX Pharmacy Chain Joint Stock Company had revenue of 5.44B CNY in the quarter ending March 31, 2025, a decrease of -1.88%. This brings the company's revenue in the last twelve months to 22.25B, down -1.25% year-over-year. In the year 2024, LBX Pharmacy Chain Joint Stock Company had annual revenue of 22.36B, down -0.36%.
Revenue (ttm)
22.25B
Revenue Growth
-1.25%
P/S Ratio
0.64
Revenue / Employee
554.51K
Employees
40,132
Market Cap
14.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.36B | -79.88M | -0.36% |
Dec 31, 2023 | 22.44B | 2.26B | 11.21% |
Dec 31, 2022 | 20.18B | 4.48B | 28.54% |
Dec 31, 2021 | 15.70B | 1.73B | 12.38% |
Dec 31, 2020 | 13.97B | 2.30B | 19.75% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |